- Home
- ABEO vs UROY Comparison
ABEO vs UROY Comparison
Compare ABEO & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- UROY
- Stock Information
- Founded
- ABEO 1974
- UROY 2017
- Country
- ABEO United States
- UROY Canada
- Employees
- ABEO N/A
- UROY N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- UROY
- Sector
- ABEO Health Care
- UROY
- Exchange
- ABEO Nasdaq
- UROY Nasdaq
- Market Cap
- ABEO 332.0M
- UROY 336.8M
- IPO Year
- ABEO 1980
- UROY N/A
- Fundamental
- Price
- ABEO $6.26
- UROY $2.62
- Analyst Decision
- ABEO Strong Buy
- UROY Strong Buy
- Analyst Count
- ABEO 6
- UROY 2
- Target Price
- ABEO $18.00
- UROY $4.00
- AVG Volume (30 Days)
- ABEO 611.9K
- UROY 3.4M
- Earning Date
- ABEO 08-19-2025
- UROY 08-19-2025
- Dividend Yield
- ABEO N/A
- UROY N/A
- EPS Growth
- ABEO N/A
- UROY N/A
- EPS
- ABEO N/A
- UROY N/A
- Revenue
- ABEO N/A
- UROY $11,285,840.00
- Revenue This Year
- ABEO N/A
- UROY $126.69
- Revenue Next Year
- ABEO $322.37
- UROY N/A
- P/E Ratio
- ABEO N/A
- UROY N/A
- Revenue Growth
- ABEO N/A
- UROY N/A
- 52 Week Low
- ABEO $3.93
- UROY $1.43
- 52 Week High
- ABEO $7.32
- UROY $3.30
- Technical
- Relative Strength Index (RSI)
- ABEO 47.50
- UROY 49.24
- Support Level
- ABEO $6.18
- UROY $2.42
- Resistance Level
- ABEO $6.94
- UROY $3.13
- Average True Range (ATR)
- ABEO 0.27
- UROY 0.17
- MACD
- ABEO -0.05
- UROY -0.04
- Stochastic Oscillator
- ABEO 18.07
- UROY 22.86
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About UROY Uranium Royalty Corp.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is the investment in a portfolio of uranium interests.